Piramal Pharma Ltd

The document provides a transcript of Piramal Pharma Limited's conference call discussing its unaudited financial results for the quarter and half year ended 30 September 2026. The transcript is available on the company's website as required by SEBI regulations. The call included discussions on standalone and consolidated financial performance, though specific figures or management commentary are not detailed in the provided text. The company's registered office, contact information, and stock exchange listings are included in the document. The filing adheres to regulatory requirements for disclosure.

The document is a routine compliance filing with no explicit positive or negative language.